The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster — Stella

Recruiting

Back to Herpes Zoster trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Beijing Tiantan Hospital, Beijing, Beijing 100070, Beijing

Key details

Sponsor

Beijing Tiantan Hospital

Enrollment target

~750 participants

Started

December 2025

Primary completion

September 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov